CTOs on the Move

APP Pharmaceuticals

www.apppharma.com

 
APP Pharmaceuticals is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 10K-50K
  • Annual Revenue: $100-250 Million
  • www.apppharma.com
  • 1501 E Woodfield Rd Ste 300e
    Schaumburg, IL USA 60173
  • Phone: 847.969.2700

Executives

Name Title Contact Details

Similar Companies

Jubilant Pharma

Follow us for career advice, news & jobs. Find your Formula for Success at Jubilant Pharma! Subsidiaries: HollisterStier, Cadista, Radiopharma, and JGL.

Opti Medical Systems

OPTI Medical Systems leverages advanced technologies to develop reliable, cost-effective point-of-care and laboratory diagnostic solutions.

Evara Health

Family medicine, primary care, and dental service provider for the underserved and uninsured communities of Pinellas County.

UroGen

UroGen Pharma is a biopharmaceutical company that builds novel solutions to revolutionize the way specialty cancers and urologic diseases are treated – because patients deserve better options. Our vision is grounded in our RTGel™ drug delivery technology platform, our promising pipeline, and a collaborative drive for bold results. Our existing technology: the RTGel drug delivery platform has the potential to be applied to a variety of unmet medical needs. RTGel reverse-thermal hydrogel is liquid at lower temperatures and converts to gel form at body temperature, offering the opportunity to make local therapy a more effective treatment. Our promising pipeline: Ranging from pre-clinical to Phase III, we currently have multiple candidates in our pipeline, which are furthering the study of potential treatment advances in urology, uro-oncology, and immunology. Our collaborative drive: We are part of a broad ecosystem of partners who are seeking to improve patient care; these connections are vital to our commitment to offer new pathways and advance solutions. We currently have an exclusive worldwide license agreement with Allergan™ to evaluate the RTGel platform, an early-stage feasibility agreement with Janssen Pharmaceuticals™, and are continually evaluating new opportunities.